Minds + Assembly Expands Healthcare Platform by Partnering with BOLDSCIENCE
Minds + Assembly has announced its strategic partnership with BOLDSCIENCE, a full-service medical communications agency, to expand its world-class healthcare communications and commercialization platform. The collaboration will enhance Minds +…
Burjeel Holdings and Response Plus Launch $1M Human Energy Health Award
Burjeel Holdings and Response Plus Launch $1 Million Human Energy Health Award at ADIPEC 2024Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services…
Inocras and Summit Pharma Partner to Transform Clinical Genomics in Japan
Inocras Inc. (San Diego, CA; President & CEO: Jehee Suh) and Summit Pharmaceuticals International Corporation (Tokyo, Japan; President & CEO: Katsuya Okuyama) have signed a Memorandum of Understanding (MOU) to…
Endologix Presents 36-Month DETOUR2 Study Results at 2024 VIVA
Endologix LLC, a global leader in medical devices for vascular disease, today revealed the final 36-month results of its DETOUR2 Study. The DETOUR System provides an innovative solution for treating…
Fusion Orthopedics Wins USPTO Judgment Against Extremity Medical
Fusion Orthopedics, LLC has secured a major victory against Extremity Medical, LLC following a ruling by the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB). The PTAB…
MaaT Pharma Reports Q3 2024 Results, Business Update & Management Changes
MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech leader in developing microbiome-based therapies for cancer, today provided an update on its activities and financial performance for the third quarter of 2024,…
e4shield™: New Frontline Weapon Against Viruses at MEDICA
e4life, a joint venture formed by two global leaders—ELT Group, a world leader in electronic defense, and Lendlease, experts in large-scale urban regeneration—will present its e4shield™ technology at MEDICA 2024.…
Anumana’s AI ECG Technology Recognized in CMS 2025 Rule, Expanding Cardiovascular Care
Anumana, a leading AI-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has recognized its low ejection fraction (LEF) ECG-AI™ technology in the 2025 Hospital…
Genmab to Highlight Epcoritamab-bysp Development at 2024 ASH Annual Meeting
Genmab A/S (Nasdaq: GMAB) today announced that over 20 abstracts evaluating epcoritamab-bysp (EPKINLY®), a subcutaneously administered T-cell engaging bispecific antibody, will be presented at the 66th Annual Meeting of the…
Shelley Gandhi Joins ELIQUENT to Lead Expanded Pharmacovigilance Services
ELIQUENT Life Sciences, a global regulatory consulting firm, is pleased to announce the addition of Shelley Gandhi, a renowned pharmacovigilance (PV) expert, to its team. This strategic hire strengthens ELIQUENT’s…
Immunis Launches Preclinical Studies for Canine Muscle Atrophy Treatment
Immunis, Inc., a clinical-stage biotechnology company focused on developing innovative secretomes for age-related diseases and immune dysfunction, has launched non-terminal safety studies for canine muscle atrophy in collaboration with VetBio…
LumiThera Receives FDA Approval for Valeda Treatment for Dry AMD
LumiThera Inc., a medical device company specializing in photobiomodulation (PBM) therapy for ocular conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for its…